Institute of Nano Science and Technology , Mohali, Punjab - 160062, India.
School of Bioengineering and Biosciences, Lovely Professional University , Phagwara, Punjab - 144411, India.
ACS Chem Neurosci. 2017 Oct 18;8(10):2105-2117. doi: 10.1021/acschemneuro.7b00207. Epub 2017 Aug 25.
The window of neurological maladies encompasses 600 known neurological disorders. In the past few years, an inordinate upsurge in the incidences of neuronal ailments with increased mortality rate has been witnessed globally. Despite noteworthy research in the discovery and development of neural therapeutics, brain drug delivery still encounters limited success due to meager perviousness of most of the drug molecules through the blood-brain barrier (BBB), a tight layer of endothelial cells that selectively impedes routing of the molecules across itself. In this Review, we have tried to present a comprehensive idea on the recent developments in nanoparticle based BBB delivery systems, with a focus on the advancements in receptor targeted polymeric nanoparticles pertaining to BBB delivery. We have also attempted to bridge the gap between conventional brain delivery strategies and nanoparticle based BBB delivery for in-depth understanding. Various strategies are being explored for simplifying delivery of molecules across the BBB; however, they have their own limitations such as invasiveness and need for hospitalization and surgery. Introduction of nanotechnology can impressively benefit brain drug delivery. Though many nanoparticles are being explored, there are still several issues that need to be analyzed scrupulously before a real and efficient BBB traversing nanoformulation is realized.
神经疾病的范畴包括 600 种已知的神经疾病。在过去的几年中,全球范围内神经元疾病的发病率和死亡率都呈异常上升趋势。尽管在神经治疗药物的发现和开发方面进行了引人注目的研究,但由于大多数药物分子通过血脑屏障(BBB)的通透性极低,而 BBB 是一层紧密的内皮细胞层,选择性地阻碍了分子的自身传输,因此脑药物输送仍然只取得了有限的成功。在这篇综述中,我们试图就基于纳米颗粒的 BBB 递药系统的最新发展提出一个全面的观点,重点介绍针对 BBB 递药的受体靶向聚合物纳米颗粒的进展。我们还试图在传统的脑递药策略和基于纳米颗粒的 BBB 递药之间架起桥梁,以进行深入了解。目前正在探索各种简化分子通过 BBB 输送的策略;然而,它们都有自己的局限性,如侵袭性以及需要住院和手术。纳米技术的引入可以为脑药物输送带来显著的好处。尽管有许多纳米颗粒正在被探索,但在实现真正有效的 BBB 穿越纳米制剂之前,仍有几个问题需要仔细分析。
J Control Release. 2018-10-9
Biomater Sci. 2016-2
Expert Opin Drug Deliv. 2019-2-26
Nanomedicine (Lond). 2012-8
J Neuroimmune Pharmacol. 2017-3
Expert Opin Drug Deliv. 2018-3-1
J Neuroimmune Pharmacol. 2016-7-23
Adv Drug Deliv Rev. 2018-10-26